openPR Logo
Press release

Pacemaker Market: Global Outlook and Competitive Dynamics 2023

04-14-2017 02:46 PM CET | IT, New Media & Software

Press release from: TMR - Research Reports

Pacemaker Market: Global Outlook and Competitive Dynamics 2023

Pacemaker is a small device which is placed in chest or abdomen to control the heart rhythm. Arrhythmia is a clinical condition in which rhythm of the heart becomes irregular. The device uses low intensity electrical pulses to correct the abnormal heart rhythm in various conditions such as tachycardia (fast heart beats), brachycardia (slow heart beats), and blockages in heart electrical pathway.Major risk factors to develop the arrhythmia are unhealthy diet, physical inactivity, and comsumption of tobacco, and alcohol. Additionally, increased blood lipid level, glucose, and blood pressure level, overweight and obesity are the major factors to cause the cardiovascular diseases. Pacemakers are placed temporary or permanently inside the body depending on the clinical condition. Temporary pacemakers are generally placed transcutaneous, transvenous or epicardiailly. They are generally used during hospitalization and to monitor the patient continuously when the arrhythmia is expected to be temporary and eventually resolved. Whereas, modern pacemakers have been developed which are externally programmable.

Browse Complete Report Details of this Market at: http://www.transparencymarketresearch.com/pacemaker-market.html

The global pacemaker market has been segmented by types and application. Pacemaker types comprisesimplantable pacemakers and external pacemakers. Implantable pacemaker segment is further categorized into single chamber pacemaker and dual chamber pacemaker. Based on the applications global pacemaker market is segmented into unipolar, and bipolar. Unipolar pacemaker makes a single contact with heart whereas bipolar pacemaker contacts the heart twice to regulate the heart rhythm.Geographically, global pacemaker market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Rest of the World. North America dominates the global pacemaker market due to increasing prevalence of heart diseases, growing acceptance to the technology, and technological advancements. Asia Pacific is expected to grow at a faster rate during the forecast period. Major driving factors for emerging countries in the Asia Pacific such as India and China are large pool of patients coupled with rising government funding.

Presently, implantable pacemaker segment dominates the global pacemaker market. In implantable pacemaker,dual chamber pacemakersaccount for the largest share due to presence of two leads responsible for more resembles to the normal activity of the heart. Continuous follow up is necessary by the patient who have implantable pacemaker. However, externally programmable pacemaker is expected to grow at a highest CAGR due to its use in emergency condition, and more compliant to patient.

Global pacemaker market is expected to grow at a faster rate due to increasing cardiovascular diseases, growing awareness about newer technologies, and government initiatives for enhancing reimbursement policies.Additionally, changing life style, increasing obesity, physical inactivity could fuel the market in near future. According to, Centers for Disease Control and Prevention (CDC) it is estimated that 2.7 million - 6.1 million people in the United Statesare diagnosed with atrial fibrillation (Type of arrhythmia) and the number is expected to grow during the forecast period.According to World Health Organization (WHO), cardiovascular diseases are number one cause of death and representing 31% of all global death. Thus, all the above mentioned factors are expected to drive the market. However, cardiac pacemaker malfunctioning is a major cause that might restrict the uptake of pacemakers to some extent. Failures such as ineffective sensing, and exhaustion of batteries impose the replacement of pacemaker hence manufacturers should have control over medical as well as electronics aspects of pacemaker. Additionally, high cost, and lack of skilled professional’s restraint the growth of the market.

Obtain the Sample PDF Research Report for this Market at: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6586

Some of the major players in global pacemaker market are Medtronic plc, Biotronik GmbH & Co. KG, Boston Scientific Corporation, St. Jude Medical, Inc., Zoll Medical Corporation, Sorin Group, and Vitatron Holding B.V.

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pacemaker Market: Global Outlook and Competitive Dynamics 2023 here

News-ID: 502805 • Views: …

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during…
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the…
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to…
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment…

All 5 Releases


More Releases for Pacemaker

Global Artificial Pacemaker Market Demand 2020-2025
This report also researches and evaluates the impact of Covid-19 outbreak on the Artificial Pacemaker industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Artificial Pacemaker and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.). GLOBAL INFO RESEARCH has recently published a research report titled, [Global and Japan Artificial Pacemaker Market 2020 by Manufacturers, Type and Application, Forecast to…
Global Temporary Pacemaker Market Research Report
This report studies the global Temporary Pacemaker market status and forecast, categorizes the global Temporary Pacemaker market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Medtronic Osypka Medical Biotronik St.Jude Medical Shree Pacetronix Oscor Cardiologic Geographically, this report studies the top producers…
Global Pacemaker Devices Market Research
A Global Pacemaker Devices Market is a little gadget that is utilized to manage your heart musicality. The Global Pacemaker Devices Market advertise has been assessed as consistently developing business sector and it is normal that the market will keep on developing correspondingly soon. Cardiovascular pacemaker are the fake heart cadence the board gadgets which regularize the pulses by sending the electrical driving forces to the heart. Outside pacemakers are…
Cardiac Pacemaker Market: Asia Pacific Shows High Growth Scope in Cardiac Pacema …
The global cardiac pacemakers market is predicted to witness a substantial growth in the forthcoming years, according to Transparency Market Research (TMR). The market is featured by the presence of three leading companies, namely Boston Scientific, Medtronic and St. Jude Medical, who cumulatively hold over 76% of the total market share. The industry is marked with high competition between the leading players. Medtronic, a leading player, has gained a high…
A Comprehensive study exploring Implantable Cardiac Pacemaker Market 2018-2025|K …
This report studies the global market size of Implantable Cardiac Pacemaker in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Implantable Cardiac Pacemaker in these regions. This research report categorizes the global Implantable Cardiac Pacemaker market by top players/brands, region, type and end user. This report also studies the global Implantable Cardiac Pacemaker market status, competition…
Global Pacemaker Industry 2018-2025 Segmented By Products (Implantable Pacemaker …
Pacemaker is a medical device implanted in the chest energy to treat the abnormal heartbeat. This device generates electrical pulses of low energy that regularize the heartbeat. Two types of pacemakers are available in the market, namely, implantable pacemaker and external pacemaker. The patient who is suffering from arrhythmia, heart block, long QT syndrome, and atrial fibrillation will need a cardiovascular treatment through which pacemaker is implanted in the chest. The…